Lumosa Approves Management Changes, Effective February 1, 2022
January 21, 2022 at 04:04 am EST
Lumosa Therapeutics Co., Ltd. approved the appointment of Financial Officer¡BAccounting Officer and Spokesperson. Name, title, and resume of the previous position holder: Financial Officer, Accounting Officer and Acting Spokesperson¡GHeidi Pan /Senior Manager, Administrative Division. Name, title, and resume of the new position holder: Financial Officer, Accounting Officer and Acting Spokesperson¡GCharlene Yang
/Senior Manager, Administrative Division/Bioengine Technology Development INC. Investment Manager. Reason for the change: Personal Reason. Effective date is February 1, 2022.